Nalka Plans Major IPO for Health Unit, Targeting Over $500 Million

Nalka, a prominent player in the pharmaceutical sector, is reportedly gearing up for an initial public offering (IPO) of its health unit, with expectations to raise at least $500 million. This significant move underscores Nalka's strategic focus on its healthcare division, which has been gaining traction amid increasing global demand for innovative health products and solutions.

Continue reading